About VNIR
VNIR is a company based in Bengaluru (India) founded in 2017 by Meher Kiran Prakash Ayalasomayajula and Thimmaiah Govindaraju. VNIR has raised $724.46 thousand across 5 funding rounds from investors including Startup Karnataka, Venkata Prashanth Gangu and Hari P Thadakamalla. VNIR operates in a competitive market with competitors including ARTMS, NorthStar Medical Radioisotopes, Niowave, Nanovista and Ground Fluor Pharmaceuticals, among others.
- Headquarter Bengaluru, India
- Founders Meher Kiran Prakash Ayalasomayajula, Thimmaiah Govindaraju
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vnir Biotechnologies Private Limited
- Date of Incorporation 11 Apr, 2017
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$16.5 K (USD)-7.36as on Mar 31, 2022
-
Net Profit
-$82.27 K (USD)-51.17as on Mar 31, 2022
-
EBITDA
-$69.69 K (USD)-61.67as on Mar 31, 2022
-
Total Equity Funding
$724.46 K (USD)
in 5 rounds
-
Latest Funding Round
$284.98 K (USD), Angel Round
Nov 01, 2021
-
Investors
Startup Karnataka
& 37 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of VNIR
VNIR has successfully raised a total of $724.46K across 5 strategic funding rounds. The most recent funding activity was a Angel Round of $284.98 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VNIR
VNIR has secured backing from 38 investors, including angel and institutional investors. Prominent investors backing the company include Startup Karnataka, Venkata Prashanth Gangu and Hari P Thadakamalla.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Support for startups in Karnataka is delivered through policies, funding, and networking services.
|
Locked | Locked | Locked | |
|
VP
Venkata Prashanth Gangu |
-
|
Locked | Locked | Locked |
|
HP
Hari P Thadakamalla |
-
|
Locked | Locked | Locked |
Investor details for VNIR
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VNIR
Investment portfolio details for VNIR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VNIR
Detailed financials for VNIR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vnir Comparisons
Peer comparison for VNIR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VNIR
VNIR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, NorthStar Medical Radioisotopes, Niowave, Nanovista and Ground Fluor Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| Locked | Locked | Locked |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| Locked | Locked | Locked |
Devices and radioisotopes for nuclear imaging are provided by Niowave.
|
|
| Locked | Locked | Locked |
Multimodal visualization agents are developed for image-guided interventions.
|
|
| Locked | Locked | Locked |
Proprietary chemistry for pharmaceutical synthesis is developed by the company.
|
|
| Locked | Locked | Locked |
Radioisotope probes for medical imaging diagnostics are manufactured.
|
Detailed competitors of VNIR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vnir
Complete news archive for VNIR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VNIR
VNIR was founded in 2017.
VNIR is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
VNIR is a funded company, having raised a total of $724.46K across 5 funding rounds to date.
Annual revenue of VNIR is $16.5K as on Mar 31, 2022.
VNIR was founded in 2017 in Bengaluru, India, within the biotechnology sector. Infrared fluorescence-based imaging and diagnostic molecules are developed by the company for applications in live-cell imaging and early detection of conditions such as Alzheimers disease, malaria, and kidney failure. Probes that absorb green light and emit red light are utilized in ROS staining, mitochondria staining, and plant protoplast staining.
VNIR's top competitors include ARTMS, NorthStar Medical Radioisotopes and Niowave.
VNIR has 38 investors. Key investors include Startup Karnataka, Venkata Prashanth Gangu, Hari P Thadakamalla, Arvind Reddy Battula, and Jagadish B Mendu.
The valuation of VNIR is $4.28M as of Nov 2021.